Both Semaglutide and Mounjaro represent new approaches to treating type 2 diabetes, and increasingly, excess weight. Semaglutide is a combined agonist that targets two chemicals involved in glucose regulation: GLP-1 https://bookmarkunit.com/story22058824/comprehending-tirzepatide-mounjaro-your-detailed-explanation